Stay updated with breaking news from Omeros Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Omeros Co. (NASDAQ:OMER – Free Report) – Equities researchers at Cantor Fitzgerald decreased their FY2024 earnings per share estimates for Omeros in a note issued to investors on Thursday, May 16th. Cantor Fitzgerald analyst O. Brayer now expects that the biopharmaceutical company will post earnings per share of ($1.81) for the year, down from their […]
Omeros Co. (NASDAQ:OMER – Free Report) – Equities researchers at Cantor Fitzgerald cut their FY2024 EPS estimates for Omeros in a research report issued on Thursday, May 16th. Cantor Fitzgerald analyst O. Brayer now anticipates that the biopharmaceutical company will post earnings per share of ($1.81) for the year, down from their previous forecast of […]
Omeros Co. (NASDAQ:OMER – Get Free Report) Director Peter A. Md Demopulos acquired 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 15th. The stock was purchased at an average cost of $1.53 per share, for a total transaction of $15,300.00. Following the acquisition, the director now owns 208,516 shares […]
Analysts’ downgrades for Saturday, August 12th: Cheesecake Factory (NASDAQ:CAKE) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Central Garden & Pet (NASDAQ:CENTA) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating. Cheniere Energy Partners (NYSE:CQP) was downgraded by analysts at StockNews.com from a strong-buy […]
Omeros Co. (NASDAQ:OMER – Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.43 and traded as high as $5.82. Omeros shares last traded at $5.71, with a volume of 639,495 shares trading hands. Analysts Set New Price Targets Separately, StockNews.com raised shares […]